Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by amorakon Apr 13, 2007 11:30am
469 Views
Post# 12601693

RE: two weeks or two months

RE: two weeks or two monthsDon't even think of the bonus being an influence. If shareholders ever thought that an RVX buyout price was influenced by an RVX-imposed deadline for bonus purposes then there'd be blood in the streets. Besides, every extra buck the insiders get is another 12 or 13 million bucks in the insiders' pockets. That makes the 5 million bonus look kind of pale in comparison. The stock should behave like there is no bonus deadline but I don't have a lot of respect for the opinions of shareholders. If anybody sells because of the missed bonus then they are truly selling their shares for no reason. You just watch though, a trader or six will sell a few into the bids, the price will drop a little and then there'll be a little selloff triggered. The traders buy back, Bob's yer uncle, and somebody's on the outside lookin' in. Oh the market is such fun...
Bullboard Posts